Delivery Order SPE2DB25D3404-SPE2DB26FULZV
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 14, 2025, for Ingrezza 40 mg capsules (30-count). This competitively awarded, firm fixed-price delivery order has a ceiling value of $3,676.12 and is scheduled for completion by September 5, 2025. The contract utilizes no set-aside designation and represents a child award under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a $4,049.61 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Ingrezza 60 mg capsules (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 23, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Ingrezza 40 mg capsules (30-count units) valued at $7,748.14. This firm fixed-price delivery order, which will be completed by November 24, 2025, carries no set-aside designation and represents a competitively awarded transaction. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and falls under the...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.69 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) on November 5, 2025, with an ultimate completion date of November 28, 2025. This firm fixed-price, non-set-aside contract represents a competitive award for pharmaceutical products supporting federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Ingrezza 40 mg capsules (30-count units) valued at $3,676.12. This is a firm fixed-price delivery order with an ultimate completion date of October 20, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order contract valued at $4,049.61 on August 11, 2025, for the supply of Ingrezza 60 mg capsules (quantity: 30 units) to support the Defense Medical Supply Chain. The contract is structured as a firm fixed price delivery order with an ultimate completion date of September 2, 2025. This award represents a non-competitive, non-set-aside transaction executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the Defense...
- The Defense Logistics Agency awarded a competitively competed delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Ingrezza 40 mg capsules (30-count packages) valued at $11,622.18, with completion required by December 1, 2025. This firm fixed price delivery order represents a non-set-aside award and will be fulfilled from the vendor's corporate office located in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed-price arrangement. The contract ceiling value is $12,083.10, with an ultimate completion date of October 17, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which holds a total value of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $4,027.70 by the Defense Logistics Agency on September 8, 2025, for the supply of Ingrezza 80 mg capsules (30-count). This non-set-aside competitive award is scheduled for completion by September 29, 2025, and represents a single transaction under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $8,077.31 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ingrezza 60 mg capsules (30-count units). This competitively awarded, firm fixed-price contract is scheduled for completion by October 9, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA....
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB26FULZVDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on November 6, 2025, for $4,027.69 to supply Ingrezza 80 mg capsules (30-count units). This is a firm fixed-price contract with a completion date of December 1, 2025, and no set-aside designation was used. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as the prime vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. Ingrezza is a prescription antipsychotic medication used to treat involuntary movement disorders in patients with schizophrenia or bipolar disorder. AmerisourceBergen, as a major pharmaceutical distributor, regularly supplies brand-name and generic medications to federal military and veteran healthcare systems through competitive awards. The company's extensive portfolio includes specialty medications across multiple therapeutic domains, positioning it as a critical vendor for the Defense Logistics Agency's medical supply chain operations serving the Defense Health Agency and other federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 11/6/25 |